# OnCo record astellas (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/astellas/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "astellas" ;
  schema:name "Astellas"@en ;
  schema:alternateName "OSI Pharmaceuticals"@en ;
  schema:description "Astellas co-owns Padcev and makes Vyloy, the first Claudin 18.2 drug."@en ;
  schema:url <https://onco.cc/companies/astellas/>, <https://www.astellas.com> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Astellas_Pharma> ;
  owl:sameAs <http://www.wikidata.org/entity/Q528842> ;
  schema:citation <https://www.astellas.com> ;
  schema:addressCountry "JP" ;
  onco:sections <https://onco.cc/fronts/adcs/>, <https://onco.cc/fronts/targeted-therapy/> ;
  onco:drugs <https://onco.cc/drugs/enfortumab-vedotin/>, <https://onco.cc/drugs/setidegrasib/>, <https://onco.cc/drugs/asp2138/>, <https://onco.cc/drugs/xnw27011/> ;
  onco:trials <https://onco.cc/trials/nct04076059/>, <https://onco.cc/trials/nct02960022/>, <https://onco.cc/trials/nct07005154/>, <https://onco.cc/trials/nct06792435/>, <https://onco.cc/trials/nct07488676/>, <https://onco.cc/trials/nct06901531/>, <https://onco.cc/trials/nct03816163/>, <https://onco.cc/trials/nct07475806/>, <https://onco.cc/trials/nct07421700/>, <https://onco.cc/trials/nct07566156/>, <https://onco.cc/trials/nct04821622/>, <https://onco.cc/trials/nct03505320/>, <https://onco.cc/trials/nct04225117/>, <https://onco.cc/trials/nct05520567/>, <https://onco.cc/trials/spotlight-glow/>, <https://onco.cc/trials/nct07730021/>, <https://onco.cc/trials/nct03182244/>, <https://onco.cc/trials/nct07287995/> .